These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12880960)
1. Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. De Preter K; Vandesompele J; Heimann P; Kockx MM; Van Gele M; Hoebeeck J; De Smet E; Demarche M; Laureys G; Van Roy N; De Paepe A; Speleman F Cancer Lett; 2003 Jul; 197(1-2):53-61. PubMed ID: 12880960 [TBL] [Abstract][Full Text] [Related]
2. Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR. Souzaki R; Tajiri T; Higashi M; Kinoshita Y; Tanaka S; Kohashi K; Tsuneyoshi M; Taguchi T Pediatr Surg Int; 2008 Oct; 24(10):1095-100. PubMed ID: 18726105 [TBL] [Abstract][Full Text] [Related]
3. Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations. Mora J; Akram M; Cheung NK; Chen L; Gerald WL Med Pediatr Oncol; 2000 Dec; 35(6):534-7. PubMed ID: 11107110 [TBL] [Abstract][Full Text] [Related]
4. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Mora J; Cheung NK; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald WL Cancer Res; 2001 Sep; 61(18):6892-8. PubMed ID: 11559566 [TBL] [Abstract][Full Text] [Related]
5. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells. Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058 [TBL] [Abstract][Full Text] [Related]
6. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma. Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684 [TBL] [Abstract][Full Text] [Related]
7. Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma. Hallstensson K; Thulin S; Aburatani H; Hippo Y; Martinsson T Eur J Cancer; 1997 Oct; 33(12):1966-70. PubMed ID: 9516834 [TBL] [Abstract][Full Text] [Related]
8. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR. Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551 [TBL] [Abstract][Full Text] [Related]
9. The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique. Tumer S; Altungoz O; Bagci O; Olgun HN Genet Test Mol Biomarkers; 2016 Feb; 20(2):74-80. PubMed ID: 26790040 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA 4,977-bp deletion in paired oral cancer and precancerous lesions revealed by laser microdissection and real-time quantitative PCR. Shieh DB; Chou WP; Wei YH; Wong TY; Jin YT Ann N Y Acad Sci; 2004 Apr; 1011():154-67. PubMed ID: 15126293 [TBL] [Abstract][Full Text] [Related]
11. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916 [TBL] [Abstract][Full Text] [Related]
14. Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma. Meltzer SJ; O'Doherty SP; Frantz CN; Smolinski K; Yin J; Cantor AB; Liu J; Valentine M; Brodeur GM; Berg PE Br J Cancer; 1996 Dec; 74(12):1855-61. PubMed ID: 8980382 [TBL] [Abstract][Full Text] [Related]
15. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803 [TBL] [Abstract][Full Text] [Related]
16. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Peter M; Michon J; Vielh P; Neuenschwander S; Nakamura Y; Sonsino E; Zucker JM; Vergnaud G; Thomas G; Delattre O Int J Cancer; 1992 Oct; 52(4):544-8. PubMed ID: 1399134 [TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma: clinical significance of genetic abnormalities. Brodeur GM Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728 [TBL] [Abstract][Full Text] [Related]
18. Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future. Li S; Yeo KS; Levee TM; Howe CJ; Her ZP; Zhu S Cells; 2021 Mar; 10(3):. PubMed ID: 33800887 [TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma IV-S in a patient with bilateral microphthalmia. Haupt R; Dolci A; Nantron M; Priolo E; Vittone P; Garaventa A Acta Paediatr; 1993 Dec; 82(12):1085-6. PubMed ID: 8155934 [TBL] [Abstract][Full Text] [Related]
20. Familial neuroblastoma: a complex heritable disease. Tonini GP; Longo L; Coco S; Perri P Cancer Lett; 2003 Jul; 197(1-2):41-5. PubMed ID: 12880958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]